{"url_path":"/sec/adgm/8-k/2026-05-12/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/2006986/0001104659-26-059026-index.html","accession_number":"0001104659-26-059026","cik":"0002006986","ticker":"ADGM","issuer_name":"Adagio Medical Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2006986/0001104659-26-059026-index.html","primary_entity_key":"0002006986","primary_entity_name":"Adagio Medical Holdings, Inc."},"word_count":129,"has_tables":true,"body_markdown":"**Item 2.02. Results of Operations and Financial Condition.**\n\n \n\nOn May 12, 2026, Adagio Medical Holdings, Inc.\nissued a press release announcing financial results for the quarter ended March 31, 2026, and providing a business update. A copy\nof this press release is furnished as Exhibit 99.1 and is incorporated herein by reference.\n\n \n\nThe information furnished with this Item 2.02,\nincluding Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of\n1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated\nby reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by\nspecific reference in such a filing."}